Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS

No-Receipt date 2022-03848 - 07/11/2022
No-Filing date 20220402209 - 07/11/2022
No-Granting date 3111455 - 11/11/2022
No-EPO application date 18825837.0 - 29/11/2018
No-EPO granting date 3716992 - 10/08/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 11/2022 - 12/12/2022
Expiration date 30/11/2038
Kind of title Validation of European Patent
Legal status VALID
Priorities US201762593033 P30/11/2017/US
US201862644425 P17/03/2018/US
US201862748782 P22/10/2018/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/17
A61P 27/02

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1451528 REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROADTARRYTOWN, NY 10591 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3749839 VITTI, ROBERT L.
3749840 BERLINER, ALYSON J.
3749841 CHU, KAREN

Representatives
CodeFirstnameSurnameAddressTownZip
745CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677

Contact
CodeFirstnameSurnameAddressTownZipCountry
2126CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677 GREECE

Owners History

Title Instruments

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015